Navigation Links
US releases updated clinical guidelines for HIV-associated opportunistic infections
Date:4/16/2009

The first complete update in five years of the U.S. guidelines for preventing and treating HIV-associated opportunistic infections has been released by the National Institutes of Health and the Centers for Disease Control and Prevention in cooperation with the HIV Medicine Association of the Infectious Diseases Society of America (IDSA).

The new Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents apply state-of-the-art science and medicine to 29 infectious diseases of concern. More than 140 medical experts contributed their knowledge to this edition of the guidelines, released on April 10.

"The scientific community has developed new and more accurate diagnostic tests for HIV-associated opportunistic infections during the past five years, more effective treatments for these infections and better approaches to preventing them," says Henry Masur, M.D., co-chair of the working group that revised the guidelines, chief of the Critical Care Medicine Department in the NIH clinical research hospital and a former president of IDSA. "The updated guidelines outline these advances for physicians and patients across the United States and beyond."

HIV cripples the immune systems of its human hosts, leaving them more vulnerable than the general population to numerous other infectious diseases. These HIV-associated opportunistic infections are a leading cause of hospitalization and death among HIV-infected individuals in the United States.

"Although the incidence rate of HIV-associated opportunistic infections has declined dramatically in the United States, primarily due to advances in antiretroviral therapy, these infections continue to threaten the health of many people infected with HIV," says John T. Brooks, M.D., co-author of the guidelines and leader of the HIV Clinical Epidemiology Team in CDC's Division of HIV/AIDS Prevention. "It is critical that health care providers, especially newer clinicians who may have less experience with opportunistic infections, remain able to recognize the signs and symptoms of these infections and know how to provide the most effective preventive care and treatment."

The new guidelines combine what were previously two separate publications, one for the prevention of opportunistic infections (last published in 2002) and one for their treatment (first published in 2004).

Major changes to the guidelines include

  • Emphasis on the important role of effective antiretroviral therapy in augmenting immune function, which is pivotal to preventing and managing opportunistic infections
  • Information on the diagnosis and management of immune reconstitution inflammatory syndrome, a condition in which the immune system begins to recover, but then responds to a previously acquired opportunistic infection with an overwhelming inflammatory response that worsens the symptoms of infection
  • Information on the prevention and treatment of hepatitis B and C infections
  • Information on interferon-gamma release assays for the detection of latent Mycobacterium tuberculosis infection
  • Updated information on interactions between antiretroviral drugs and drugs used to treat opportunistic infections
  • A new section on malaria and other tropical diseases that may become opportunistic infections in HIV-infected immigrants to the United States and in HIV-infected American travelers

HIV-associated opportunistic infections in the United States often occur in people who are unaware that they have HIV; in such cases, the opportunistic infection may be the first sign of late-stage HIV disease. HIV-associated opportunistic infections also tend to occur among Americans who are aware of their HIV infection but are not receiving treatment for it, who do not or cannot take antiretroviral therapy, who take antiretroviral therapy but fail to benefit from it, or who do not receive needed preventive care for an opportunistic infection.

A draft of the new guidelines was released in June 2008 for public comment, and an early edition of the new guidelines was published online on March 24. The finalized new Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents are accessible at http://www.cdc.gov/mmwr/pdf/rr/rr5804.pdf and http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5804a1.htm. These guidelines, as well as all federal HIV prevention and treatment guidelines, can be found on the AIDSInfo Web site at http://www.aidsinfo.nih.gov/Guidelines/Default.aspx?MenuItem=Guidelines.

A final draft of the corresponding pediatric version of these guidelines, Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-Exposed and HIV-Infected Children, is under review and will be published later this year.


'/>"/>

Contact: Bill Schmalfeldt
schmalfeldtb@cc.nih.gov
301-496-2563
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Related medicine news :

1. Capgemini Releases New Study on Financial Impact of Masimo Noninvasive and Continuous Hemoglobin (SpHb(TM))
2. Glenwood Systems, LLC Releases EMR Practice Management and Medical Billing Process Improvement Program
3. Sentillion Releases Healthcare Do It Yourself Tool for Single Sign-On and Context Management Application Interfaces
4. Illinois Lottery Releases New MS Ticket, Dash! For Cash
5. U.S. Department of Health & Human Services Releases Public Service Announcements to Encourage Healthy Lifestyles
6. NIH releases the first research plan to reduce the burden of digestive diseases
7. APHA Releases Agenda for Health Reform
8. Pennsylvania Patient Safety Authority Releases March Advisory
9. Consumer Group Releases New Study About Defective Heart Devices and Implants; Patients Arrive in DC Tomorrow
10. Providence Service Corporation Releases Fourth Quarter and Audited Year End 2008 Results
11. HCLA Releases Report on Status of Medical Liability Reform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... "FCPX editors can ... inside of Final Cut Pro X," said Christina Austin - CEO of Pixel Film ... Final Cut Pro X users can now reveal the media of their ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to ... of individuals in the United States and Canada wear eyeglasses. Once considered to be ... vision and make a fashion statement. Even celebrities use glasses as a way of ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Consumers have taken a ... have placed more emphasis on patient outcomes. ... programs in the pharmaceutical industry have evolved beyond ... pharmaceutical companies are focusing on becoming more patient-oriented ... products and services that improve health. ...
(Date:6/24/2016)... 2016 Dublin ... addition of the " Global Markets for Spectroscopy ... This report focuses on the ... review, including its applications in various applications. The report ... includes three main industries: pharmaceutical and biotechnology, food and ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American Respiratory ... testing company, is now able to perform sophisticated lung assessments in ... Medical Technologies , Inc. Patients are no longer ... to ndd,s EasyOne PRO ® , ARL patients like Jeanne R. ... testing done in the comfort of her own home. ...
Breaking Medicine Technology: